Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Feeling that also. I'm hoping the route of administration direct to the lungs aerosol should be critical as opposed to those nasal drops which perhaps dont get there. Thanks for that link. I noted in the video he reiterated that the patients were quite unwell in the hospital setting. Secondly the placing helped them to fund the hospital trial. I expect there will be a good result from the home trial.
I cant think of why next winter greenfish. There are plenty of COPD patients kicking around right now with a virus and as the company stated in a previous RNS they are going to look into using these individuals to fill the remaining 11 slots.
I don’t think they intend to finish it, they have asked for unblinding with the hope it compliments Covid19 trials and they push it all through together. I can’t see why you would unblind to then recruit 11 more people and then assess the data again? They must have put forward a good case to get approval. Both RNS are really positive only draw back is July results not June, give us the TR1 that tells us under 3%! Not logical response today.
your right it only says it has been paused. and they have recruited 109 out of the 120. So do you think that means all 109 have recived a dose or placebo. will they get any permissions for treatment of copd if they have not finnished the trial and will we be locked down again next winter? so we might not be able to compleat then. They could always do another video trial.
If this one is accepted
Sorry,
But there is no evidence that the trial has been stopped, otherwise they would have said that ....
The trial is continuing but we probably would'nt be able to fill the last 11 patients until next winter ...so ...
well they had to stop the copd early. They said they had enough information for results maybe the results were not conclusive so they are hoping the good covid 19 results out weigh any incoclusive results from the copd trial.
I'm having fun being negative ( Balanced :-)) but if it does go that way at least it won't be a shock
They were nearly their with the numbers on the COPD trial in any case so given the risk of taking patients into hospital with underlying conditions in these COVID times to finish off the 120 compliment the decision is perfectly sensible imo. These numbers on the COPD trial can lend weight to the tolerability of the drug too. Don't think anyone would argue with that really.
Sharestring,
While your opinion is very plausible it's still just one of many options to explain this change of plan ..
Can you see any other reason for this change of plan except this very POSITIVE option ?
Sorry to ask a ´ genuine long term investor ' a question like this but it's why we vary in opinions nearly always.... why do you always only mention the most positive possible reason, and never mention any other possible reason ?
Objectivity, objectivity ....
I kinda of agree.
We have learnt allot more around the home trials as well. Patient demographics, 40 mile radius....
The COPD news for me is the most exciting and it will allow the major multinational drug companies a early look at the results prior to the partnership discussions ( chairman confirmed multinationals were interested in Sept19 RNS)
Realistically, on the chance both results are entirely different, they can justify and go into detail as to why. Wouldn't promote the company releasing singular news articles with 2 opposite outcomes.
Just my opinion.
maybe some of the copd patients were covid 19 patients also
The real and only new news today ....
It's time to debate on why SNG want to show some details of this trial at roughly the same time as the hospital results ....